Market Overview

UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Allscripts Healthcare Solutions

Share:
Related MDRX
Benzinga's Option Alert Recap From June 23
Watch These 8 Huge Call Purchases In Friday Trade

In a report published Monday, Sterne Agee Group reiterated its Buy rating on Allscripts Healthcare Solutions (NASDAQ: MDRX), and raised its price target from $13.50 to $15.00.

Sterne Agee noted, “Our analysis suggests a $15-19 valuation range for MDRX shares should a go-private transaction be consummated by year-end. At the low end, this valuation range is 20% above today's closing price, while the top end implies 50% upside. As such, we have raised our price target to $15 per share from $13.50.”

Allscripts Healthcare Solutions closed on Friday at $12.42.

Latest Ratings for MDRX

DateFirmActionFromTo
Jun 2017Leerink SwannDowngradesOutperformMarket Perform
May 2017Bank of AmericaInitiates Coverage OnNeutral
Mar 2017Wells FargoUpgradesMarket PerformOutperform

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: Sterne Agee GroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (MDRX)

View Comments and Join the Discussion!